Lanean...
Successful Treatment of Chronic Hepatitis C with Triple Therapy in an Opioid Agonist Treatment Program
BACKGROUND: People who inject drugs (PWID) constitute 10 million people globally with hepatitis C virus, including many opioid agonist treatment patients. Little data exist describing clinical outcomes for patients receiving HCV treatment with direct-acting antiviral agents (DAAs) in opioid agonist...
Gorde:
| Argitaratua izan da: | Int J Drug Policy |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833390/ https://ncbi.nlm.nih.gov/pubmed/26341685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.08.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|